Drug intelligence / Profile preview

SmofKabiven E

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

SmofKabiven E is a multi-chamber parenteral nutrition emulsion developed by Fresenius Kabi, designed to provide a comprehensive supply of macronutrients and electrolytes via intravenous infusion. The product consists of three separate compartments containing an amino acid solution with electrolytes, a glucose solution, and a lipid emulsion (SMOF). The SMOF lipid component is a proprietary blend of soybean oil, medium-chain triglycerides (MCT), olive oil, and fish oil, which provides a balanced ratio of omega-3, omega-6, and omega-9 fatty acids. The "E" suffix denotes the inclusion of essential electrolytes, including sodium, potassium, magnesium, calcium, phosphate, zinc, chloride, and acetate. It is primarily indicated for adult patients requiring parenteral nutrition when oral or enteral nutrition is impossible, insufficient, or contraindicated. Clinical research is also evaluating its efficacy in maintaining nutritional status and improving outcomes in cancer patients undergoing intensive treatments like chemotherapy and immunotherapy.

Brand names
SmofKabiven ESmofKabiven
Other names
SmofKabiven ElectrolyteSmofKabiven with electrolytes

Beyond the preview

Go deeper on SmofKabiven E.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmofKabiven E.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call